Dr Lal PathLabs is focusing on innovation, including new wellness packages and high-end, super-speciality tests, with a focus ...

Agreement expands Cardio Diagnostics' global footprint and supports improved detection and management of coronary heart disease in India.

The partnership marks Cardio Diagnostics' first expansion outside the US and is focused on integrating the test within Dr. Lal PathLabs' laboratory and clinical network.

April 25 (Reuters) - Dr Lal Path Labs (DLPA.NS), opens new tab, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its ...

The launch comes at a time when Dr Lal PathLabs continues to rely on volume-led growth, having not taken a price hike in the ...

Healthcare services provider Dr Lal PathLabs might be showing up to 50 per cent fall in some trading apps today.

Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...

Dr. Lal PathLabs (DLPL), one of India’s leading diagnostic networks has launched India’s first dedicated Complement Testing Laboratory, strengthening its position as the country’s leading hub for ...

Dr Lal PathLabs Q2 Results: Dr Lal PathLabs Limited, a prominent player in the Indian diagnostic and healthcare service sector, has reported a notable financial performance for the second quarter of ...

The shares of Dr Lal PathLabs jumped more than 3 percent on October 27. This comes after the company announced that its board is set to meet on October 31 to consider a bonus issue of shares. The ...